Gyre Therapeutics Inc. (GYRE) — Capital Reinvestment Ratio
Gyre Therapeutics Inc. (GYRE) has a Capital Reinvestment Ratio of 0.06x as of March 2026, meaning it reinvests 0% of its operating cash flow ($3.18 Million) in capital expenditures ($178.00K). Check Gyre Therapeutics Inc. (GYRE) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Gyre Therapeutics Inc. Capital Reinvestment Ratio (2007–2025)
This chart tracks Gyre Therapeutics Inc.'s Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see Gyre Therapeutics Inc. (GYRE) cash flow conversion.
Annual Capital Reinvestment Ratio for Gyre Therapeutics Inc. (2007–2025)
Year-by-year Capital Reinvestment Ratio for Gyre Therapeutics Inc. from 2007 to 2025. See Gyre Therapeutics Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.18x | $1.01 Million | $1.19 Million | ▲ +255.3% |
| 2023 | 0.33x | $25.89 Million | $8.59 Million | ▼ -29.2% |
| 2022 | 0.47x | $10.68 Million | $5.00 Million | ▲ +1855.3% |
| 2010 | 0.02x | $138.30 Million | $3.31 Million | ▼ -88.0% |
| 2007 | 0.20x | $24.84 Million | $4.94 Million | — |